Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Harvest Clarification Using Depth Filtration – V 2.0

Posted on By


Biosimilars: SOP for Harvest Clarification Using Depth Filtration – V 2.0


Standard Operating Procedure for Harvest Clarification Using Depth Filtration in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/151/2025
Supersedes SOP/BS/151/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standardized procedure for clarifying harvested cell culture fluid using depth filtration systems prior to downstream purification steps in biosimilar manufacturing under GMP conditions.

2. Scope

This SOP applies to harvest clarification of mammalian cell culture processes in biosimilar production facilities using depth filters in single-use or stainless steel systems.

3. Responsibilities

  • Production: Execute harvest and filtration operation, ensure equipment integrity and documentation.
  • QA: Review batch records, filtration logs, and authorize product transfer to DSP.
  • Engineering: Maintain filter integrity testing devices and associated support systems.

4. Accountability

The Manufacturing Head is accountable for ensuring compliance with this SOP during the harvest clarification stage and for reporting deviations to QA.

5. Procedure

5.1 Preparation and Pre-Use Checks

  1. Verify the batch number, harvest vessel, and scheduled time of clarification.
  2. Ensure filter lot number, pore grade, and capacity match the BMR specifications.
  3. Check:
    • Filtration unit cleanliness
    • Filter integrity test (if applicable)
    • Drainage and venting ports are closed

5.2 Filter Setup

  1. Connect the harvest vessel outlet to the inlet of the depth filter using sterile single-use tubing or cleaned stainless steel lines.
  2. Connect the filter outlet to the clarified product collection vessel (e.g., bag or tank).
  3. Ensure flow direction arrows align with setup as per manufacturer specification.

5.3 Filtration Operation

  1. Open the transfer valve and begin filtration using controlled peristaltic or diaphragm pump.
  2. Maintain a pressure not exceeding 1.5 bar (22 psi).
  3. Monitor:
    • Inlet and outlet pressure
    • Flow rate (L/min)
    • Turbidity at outlet (optional inline sensor)
  4. Stop filtration if pressure exceeds limits or filtrate turbidity increases above 25 NTU.

5.4 Completion and Post-Filtration Handling

  1. Flush the filter with 1–2 L of WFI to maximize recovery (if allowed in protocol).
  2. Disconnect all lines aseptically and cap the outlets of the clarified product container.
  3. Record total volume processed, duration, and final pressure readings in Annexure-1.

5.5 Filter Integrity Testing (if applicable)

  1. Perform bubble point or water intrusion test using certified device.
  2. Record results in Annexure-2: Filter Integrity Test Log.

5.6 Deviation Management

  1. Document any anomalies such as:
    • Filter rupture
    • High differential pressure
    • Turbidity spike
  2. Inform QA and raise deviation report as per SOP for deviation handling.

6. Abbreviations

  • WFI: Water for Injection
  • NTU: Nephelometric Turbidity Units
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance

7. Documents

  1. Harvest Clarification Log – Annexure-1
  2. Filter Integrity Test Log – Annexure-2

8. References

  • WHO TRS 999 – GMP for Biotherapeutic Products
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Harvest Clarification Log

Date Batch No. Filter Lot Volume (L) Start Time End Time Final Pressure (psi) Operator
04/05/2025 BS-UB-076 DF-1123A 110 10:00 11:15 18 Sunita Reddy

Annexure-2: Filter Integrity Test Log

Date Filter ID Test Type Result Pass/Fail Technician
04/05/2025 DF-1123A Bubble Point 3.2 bar Pass Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included WFI flush and turbidity monitoring steps Process improvement
See also  Biosimilars: SOP for Data Integrity in CLD Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Evaluating Freeze-Drying Parameters in Injectable Development – V 2.0
Next Post: Analytical Method Development: SOP for LOD and LOQ Determination – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version